These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2845729)

  • 41. Establishment and characterization of a novel cell line (SCCOHT-CH-1) and PDX models derived from Chinese patients of small cell ovarian carcinoma of the hypercalcemic type.
    Gao Y; Zheng K; Kang M; Xu J; Ning Y; Hu W; Li K; Kang Y; Xu C
    Hum Cell; 2023 Nov; 36(6):2214-2227. PubMed ID: 37535222
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Re-assigning the histologic identities of COV434 and TOV-112D ovarian cancer cell lines.
    Karnezis AN; Chen SY; Chow C; Yang W; Hendricks WPD; Ramos P; Briones N; Mes-Masson AM; Bosse T; Gilks CB; Trent JM; Weissman B; Huntsman DG; Wang Y
    Gynecol Oncol; 2021 Feb; 160(2):568-578. PubMed ID: 33328126
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary.
    Xue Y; Meehan B; Macdonald E; Venneti S; Wang XQD; Witkowski L; Jelinic P; Kong T; Martinez D; Morin G; Firlit M; Abedini A; Johnson RM; Cencic R; Patibandla J; Chen H; Papadakis AI; Auguste A; de Rink I; Kerkhoven RM; Bertos N; Gotlieb WH; Clarke BA; Leary A; Witcher M; Guiot MC; Pelletier J; Dostie J; Park M; Judkins AR; Hass R; Levine DA; Rak J; Vanderhyden B; Foulkes WD; Huang S
    Nat Commun; 2019 Feb; 10(1):558. PubMed ID: 30718512
    [TBL] [Abstract][Full Text] [Related]  

  • 44. c-Met inhibitors attenuate tumor growth of small cell hypercalcemic ovarian carcinoma (SCCOHT) populations.
    Otte A; Rauprich F; von der Ohe J; Yang Y; Kommoss F; Feuerhake F; Hillemanns P; Hass R
    Oncotarget; 2015 Oct; 6(31):31640-58. PubMed ID: 26436697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro and in vivo therapeutic approach for a small cell carcinoma of the ovary hypercalcaemic type using a SCCOHT-1 cellular model.
    Otte A; Rauprich F; Hillemanns P; Park-Simon TW; von der Ohe J; Hass R
    Orphanet J Rare Dis; 2014 Aug; 9():126. PubMed ID: 25103190
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type.
    Witkowski L; Carrot-Zhang J; Albrecht S; Fahiminiya S; Hamel N; Tomiak E; Grynspan D; Saloustros E; Nadaf J; Rivera B; Gilpin C; Castellsagué E; Silva-Smith R; Plourde F; Wu M; Saskin A; Arseneault M; Karabakhtsian RG; Reilly EA; Ueland FR; Margiolaki A; Pavlakis K; Castellino SM; Lamovec J; Mackay HJ; Roth LM; Ulbright TM; Bender TA; Georgoulias V; Longy M; Berchuck A; Tischkowitz M; Nagel I; Siebert R; Stewart CJ; Arseneau J; McCluggage WG; Clarke BA; Riazalhosseini Y; Hasselblatt M; Majewski J; Foulkes WD
    Nat Genet; 2014 May; 46(5):438-43. PubMed ID: 24658002
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Small cell ovarian carcinoma: genomic stability and responsiveness to therapeutics.
    Gamwell LF; Gambaro K; Merziotis M; Crane C; Arcand SL; Bourada V; Davis C; Squire JA; Huntsman DG; Tonin PN; Vanderhyden BC
    Orphanet J Rare Dis; 2013 Feb; 8():33. PubMed ID: 23433318
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Calcitonin and calcitonin receptors: bone and beyond.
    Pondel M
    Int J Exp Pathol; 2000 Dec; 81(6):405-22. PubMed ID: 11298188
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calcitonin (but not calcitonin gene-related peptide) increases mouse bone cell proliferation in a dose-dependent manner, and increases mouse bone formation, alone and in combination with fluoride.
    Farley JR; Hall SL; Tarbaux NM
    Calcif Tissue Int; 1989 Oct; 45(4):214-21. PubMed ID: 2509008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cloning, characterization, and expression of a human calcitonin receptor from an ovarian carcinoma cell line.
    Gorn AH; Lin HY; Yamin M; Auron PE; Flannery MR; Tapp DR; Manning CA; Lodish HF; Krane SM; Goldring SR
    J Clin Invest; 1992 Nov; 90(5):1726-35. PubMed ID: 1331173
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential cyclic AMP responses to calcitonin among human ovarian carcinoma cell lines: a calcitonin-responsive line derived from a rare tumor type.
    Upchurch KS; Parker LM; Scully RE; Krane SM
    J Bone Miner Res; 1986 Jun; 1(3):299-304. PubMed ID: 2845729
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stimulation of interleukin-6 production by either calcitonin gene-related peptide or parathyroid hormone in two phenotypically distinct bone marrow-derived murine stromal cell lines.
    Sakagami Y; Girasole G; Yu XP; Boswell HS; Manolagas SC
    J Bone Miner Res; 1993 Jul; 8(7):811-6. PubMed ID: 8394639
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glucocorticoid receptors and actions in subpopulations of cultured rat bone cells. Mechanism of dexamethasone potentiation of parathyroid hormone-stimulated cyclic AMP production.
    Chen TL; Feldman D
    J Clin Invest; 1979 Apr; 63(4):750-8. PubMed ID: 220282
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calcitonin stimulation of cyclic adenosine 3':5'-monophosphate production with growth inhibition in human renal adenocarcinoma cell lines.
    Kinoshita Y; Fukase M; Takenaka M; Nakada M; Miyauchi A; Fujita T
    Cancer Res; 1985 Oct; 45(10):4890-4. PubMed ID: 2992768
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of bone-seeking hormones on DNA synthesis, cyclic AMP level, and alkaline phosphatase activity in cultured cells from human posterior longitudinal ligament of the spine.
    Ishida Y; Kawai S
    J Bone Miner Res; 1993 Nov; 8(11):1291-300. PubMed ID: 8266821
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.